A Federal Court judge has allowed the plaintiffs in a class action alleging a unit of Westpac failed to detect the fraud of convicted Ponzi schemer Michael Samra to proceed with their claims against Samra’s defunct company.
HarperCollins has lost its bid for summary dismissal of a defamation lawsuit brought against it by two psychiatrists at the centre of the deep sleep therapy scandal that rocked the medical world in the 1960s and 70s.
The stakes will be high for both sides when some of the country’s top competition lawyers face off against the ACCC Tuesday in the first hearing in a closely watched criminal cartel case against three investment banks over a $2.5 billion ANZ institutional share placement.
An investor suing property investment group Aviation 3030 can’t avoid payment of half a million dollars in security for litigation costs because of a parallel enforcement action by the corporate regulator, a judge has ruled.
The Australian Patent Office has thrown out Fisher & Paykel Healthcare’s opposition to a patent for a gas supply apparatus used to treat respiratory conditions owned by California-based medical equipment manufacturer, ResMed.
Shine Lawyers has acquired boutique class action firm ACA lawyers, a deal that will create the second largest class action firm in Australia by caseload and position the firm to take advantage of an expected increase in shareholder class action work.
Consumer goods giant Reckitt Benckiser has been permanently barred from displaying select ads for its Strepfen throat lozenges, as the Federal Court dismissed proceedings filed by rival iNova Pharmaceuticals.
The litigation funder backing a class action against engineering company UGL over disclosures related to the ballooning costs of its Ichthys power project could pocket up to 30 percent of any settlement or judgment, according to a court order.
A sex discrimination lawsuit against advertising giant M&C Saatchi by a contract employee who claimed he was fired after requesting flexible hours to take care of his children has been resolved.
Building material manufacturer Amaca and distributor Seltsam have lost their appeal of a $1.5 million judgment won by a NSW resident who developed mesothelioma after working with asbestos during the 60s and 70s.